comparemela.com

J Vasc Endovasc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

AI Measures Fat Around the Heart, a Key to Predicting Heart Attacks

A collaborative group of Cedars-Sinai investigators suggest artificial intelligence can accurately assess volume, density of heart fat-both of which are linked to cardiovascular risk

United statesNew zealandChristopher haigJ vasc endovascLewisb schwartzBreakthrough devices programUnited states food drug administrationFlexstep technologyEfemoral medicalUnited states foodDrug administrationEfemoral vascular scaffold systemBreakthrough deviceChronic limb threatening ischemia

Surmodics Receives FDA 510(k) Clearance for Pounce™ LP Thrombectomy System

Addition to Pounce™ thrombectomy platform with the low-profile model will allow for efficient clot removal in below-the-knee peripheral arteries , expanding the addressable market for the. | June 14, 2023

Eden prairieUnited statesJ vasc endovascGary maharajEuropean society for vascular surgeryExchange commissionDrug administrationA national surgical quality improvement program studySurmodics incLow profilePounce thrombectomy systemChief executive officerPounce thrombectomyAcute limb ischemiaAnnual reportVascular surgery

Andexxa Phase IV trial stopped early after achieving pre-specified criteria on haemostatic efficacy versus usual care

AstraZeneca to proceed with regulatory filings to convert from conditional to full approval in the US and EU ANNEXA-I, a post-marketing Phase IV trial to assess the efficacy and safety of Andexxa in. | June 5, 2023

United kingdomUnited statesPathw cardiolStuartj connollyJ vasc endovascColl cardiolAlexion pharmaceuticals incPopulation health research instituteHeart rhythm societyAmerican society of hematologyMcmaster universityCompany on twitter astrazenecaSafety monitoring boardSenior scientistHealth research instituteMaster university

ANDEXXA Phase IV Trial Stopped Early After Achieving Pre-specified Criteria on Hemostatic Efficacy Versus Usual Care

AstraZeneca to proceed with regulatory filings to convert from conditional to full approval in the US and EU . | June 5, 2023

United kingdomUnited statesPathw cardiolJ vasc endovascColl cardiolStuartj connollyJournal of the american society hematologyHeart rhythm societySenior scientist at population health research instituteMcmaster universityAlexion pharmaceuticals incCompany on twitter astrazenecaSafety monitoring boardSenior scientistPopulation health research instituteExecutive vice president

Surmodics Announces First Patient Enrolled in PROWL Registry Study Using the Pounce™ Thrombectomy System

Registry to enroll up to 500 patients at up to 30 sites, collecting real-world outcomes data for the Pounce™ Thrombectomy System . | April 20, 2023

United statesEden prairieGary maharajSean lydenJ vasc endovascJoseph griffinJoseph campbellEuropean society for vascular surgerySurmodics incDepartment of vascular surgeryNational coVascular specialty centerA national surgical quality improvement program studyExchange commissionThrombectomy system retrospectiveSurmodics pounce

vimarsana © 2020. All Rights Reserved.